The mechanism of PRP in treating vitiligo and alopecia areata may lie in that PRP has proliferation and immunoregulatory effects, and may have the role of TGF-β in regulating local T cell immunity to achieve the purpose of relieving vitiligo and alopecia areata [18]. The gene discussed is TGFB1; the disease is vitiligo.